{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:33:41Z","timestamp":1793306021885,"version":"4.5.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1097\/jcp.0b013e3181d236ec","type":"journal-article","created":{"date-parts":[[2010,3,5]],"date-time":"2010-03-05T06:48:34Z","timestamp":1267771714000},"page":"190-192","source":"Crossref","is-referenced-by-count":51,"title":["Oral \u03949-Tetrahydrocannabinol Improved Refractory Gilles de la Tourette Syndrome in an Adolescent by Increasing Intracortical Inhibition"],"prefix":"10.1097","volume":"30","author":[{"given":"Alkomiet","family":"Hasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aribert","family":"Rothenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"M\u00fcnchau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Wobrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Falkai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veit","family":"Roessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210128","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jpsychores.2008.03.006","article-title":"The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: the epidemiological and prevalence studies.","volume":"65","author":"Robertson","year":"2008","journal-title":"J Psychosom Res"},{"key":"R2-14-20210128","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/01.nmd.0000144696.14555.c4","article-title":"Reexamining tic persistence and tic-associated impairment in Tourette's disorder: findings from a naturalistic follow-up study.","volume":"192","author":"Coffey","year":"2004","journal-title":"J Nerv Ment Dis"},{"issue":"suppl 1","key":"R3-14-20210128","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00787-007-1003-7","article-title":"Tic disorders and ADHD: answers from a world-wide clinical dataset on Tourette syndrome.","volume":"16","author":"Freeman","year":"2007","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"R4-14-20210128","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10802-006-9086-z","article-title":"Psychopathological profile in children with chronic tic disorder and co-existing ADHD: additive effects.","volume":"35","author":"Roessner","year":"2007","journal-title":"J Abnorm Child Psychol"},{"key":"R5-14-20210128","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1017\/S0012162206001290","article-title":"First-onset tics in patients with attention-deficit-hyperactivity disorder: impact of stimulants.","volume":"48","author":"Roessner","year":"2006","journal-title":"Dev Med Child Neurol"},{"key":"R6-14-20210128","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/CHI.0b013e3181b26e9f","article-title":"Meta-analysis: treatment of attention-deficit\/hyperactivity disorder in children with comorbid tic disorders.","volume":"48","author":"Bloch","year":"2009","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R7-14-20210128","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4088\/JCP.v64n0417","article-title":"Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial.","volume":"64","author":"Muller-Vahl","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"R8-14-20210128","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ana.77","article-title":"Children with comorbid attention-deficit-hyperactivity disorder and tic disorder: evidence for additive inhibitory deficits within the motor system.","volume":"49","author":"Moll","year":"2001","journal-title":"Ann Neurol"},{"key":"R9-14-20210128","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00004583-198907000-00015","article-title":"The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity.","volume":"28","author":"Leckman","year":"1989","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R10-14-20210128","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1212\/01.wnl.0000327890.02893.61","article-title":"The Gilles de la Tourette syndrome-quality of life scale (GTS-QOL): development and validation.","volume":"71","author":"Cavanna","year":"2008","journal-title":"Neurology"},{"key":"R12-14-20210128","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1113\/jphysiol.1993.sp019912","article-title":"Corticocortical inhibition in human motor cortex.","volume":"471","author":"Kujirai","year":"1993","journal-title":"J Physiol"},{"key":"R13-14-20210128","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0168-5597(92)90048-G","article-title":"Human motor evoked responses to paired transcranial magnetic stimuli.","volume":"85","author":"Valls-Sole","year":"1992","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"R14-14-20210128","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia.","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"R15-14-20210128","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.clinph.2004.03.006","article-title":"TMS and drugs.","volume":"115","author":"Ziemann","year":"2004","journal-title":"Clin Neurophysiol"},{"key":"R16-14-20210128","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/brain\/awg143","article-title":"Cannabis and the brain.","volume":"126","author":"Iversen","year":"2003","journal-title":"Brain"},{"key":"R17-14-20210128","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1615\/CritRevNeurobiol.v15.i2.10","article-title":"Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids.","volume":"15","author":"Sim-Selley","year":"2003","journal-title":"Crit Rev Neurobiol"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004714-201004000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:15:25Z","timestamp":1618035325000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201004000-00014"}},"subtitle":["A Case Report"],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3181d236ec","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}